Showing results (3251-3260 of 11,196) with videos related to
Sort By:
Pageof 1,120
Journal of Neurology|February 8, 2026
Construct validity of instrumented gait assessments in hospital and daily life mobility in patients with Parkinson's disease and atypical Parkinson's syndromes: an exploratory studyI Teckenburg, V Sidoroff, H Moradi, et al.Journal of Neurology|February 10, 2026
Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in cognitive disorders: a real-world clinical studyJordi A Matías-Guiu, Isabel Ortega-Madueño, María José Gil-Moreno, et al.Journal of Neurology|January 30, 2026
Short-term memory conjunctive binding in subjective cognitive decline: A PET biomarker-based studyM A Cecchini, A Studart-Neto, N C Moraes, et al.Journal of Neurology|January 23, 2026
Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkersMagdalena Mroczek, Corinna Preusse, Andreas Hentschel, et al.Journal of Neurology|January 30, 2026
Real-world evaluation of an automated EEG spike detection software in a tertiary centre compared to a clinical reference standardC Cook, A Auwal, S Eglese, et al.Journal of Neurology|January 31, 2026
Association of mild cognitive impairment and obesity-metabolic status in middle-aged and elderly adults: a nationwide prospective cohort studyWeijie Zhai, Anguo Zhao, Jun ZhangJournal of Neurology|March 25, 2025
Vestibular dysfunction: a hidden risk factor for Alzheimer's diseaseCarolin Anna Maria Koriath, Boris Rauchmann, Florian Schoeberl, et al.Journal of Neurology|March 25, 2025
Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS studyFilipa Ladeira, Claudia Nobrega, João Cerqueira, et al.Journal of Neurology|March 25, 2025
Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degenerationJana Kleinerova, Marlene Tahedl, Mary Clare McKenna, et al.Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.Pageof 1,120